EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.
EKF Diagnostics, the global in-vitro diagnostics company, announces that Separation Technology, Inc., a subsidiary of EKF, has moved its manufacturing and operations from Sanford, Florida to Boerne, Texas.
EKF Diagnostics, the global in-vitro diagnostics company, announces the release of a significant critical evaluation of the Quo-Test analyzer carried out by the European Reference Laboratory for Gylcohemoglobin.
EKF Diagnostics, the global in vitro diagnostics company, is looking forward to an exciting second half of 2016 as it relaunches the HemoPoint® H2 hemoglobin analyzer in the USA under the Stanbio brand.
Keep up to date with all our activities, events, exhibitions, promotions, investor news & more.